(lp0
S'Cyclacel Pharmaceuticals: Is There Anything Left In The Tank? Seeking Alpha - Mar 9, 2017 Cyclacel Pharmaceuticals Inc.,  is a small biopharmaceutical company that works on developing oral therapies for the treatment of various cancers and diseases with high unmet medical need.Cyclacel Pharmaceuticals, Inc.  Rises on Publication of Data - StockNewsUnionAnalyst Hints Surrounding Cyclacel Pharmaceuticals, Inc.  - Post Analyst'
p1
aS"Guess Who Cyclacel Pharmaceuticals Inc.  Shares Small Cap Exclusive  - Feb 28, 2017 For those not familiar with the company, Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology.Cyclacel Pharmaceuticals Inc  Upgraded to Buy at Zacks Investment Research - The Cerbat GemCyclacel Pharmaceuticals, Inc.'s  stock price is Worth at $3.42 - Hot Stocks Point"
p2
aS"Cyclacel Pharmaceuticals, Inc.'s  CEO Spiro Rombotis on Q2 2016 Results ... Seeking Alpha - Aug 10, 2016 Good afternoon and welcome to the Cyclacel Pharmaceutical's Second Quarter 2016 Results Conference Call and Webcast. Today's call is being recorded."
p3
aS"CYCLACEL PHARMACEUTICALS, INC.  Files An 8-K Other Events Market Exclusive - Mar 13, 2017 On March 7, 2017, the Board of Directors  of Cyclacel Pharmaceuticals, Inc.  declared a quarterly cash dividend in the amount of $0.15 per share on the Company's 6% Convertible Exchangeable Preferred Stock (Preferred&nbsp;..."
p4
aS"Analyst rating score stands at 2.00 while Cyclacel Pharmaceuticals, Inc.'s ... Hot Stocks Point - 7 hours ago Cyclacel Pharmaceuticals, Inc.  stock price ended its day with loss -2.78% and finalized at the value of $3.85."
p5
aS"Cyclacel's Date With Decitabine Seeking Alpha - Aug 22, 2016 Cyclacel's  long-suffering shareholders will shortly see the outcome of its seemingly endless, so-called Seamless trial of sapacitabine in elderly patients with newly diagnosed acute myeloid leukaemia, after the study finally reached the&nbsp;..."
p6
aS"Insider Trading Activity Cyclacel Pharmaceuticals, Inc.   Major ... Market Exclusive - Feb 28, 2017 Kevin C Tang , Major Shareholder of Cyclacel Pharmaceuticals, Inc.  reportedly Bought 134,200 shares of the company's stock at an average price of 4.34 for a total transaction amount of $582,428.00 SEC Form."
p7
aS"Here's Why Cyclacel Pharmaceuticals Inc  Could Have A Rough December Market Exclusive - Nov 18, 2016 Cyclacel Pharmaceuticals Inc  soared throughout the US session on Thursday, gaining as much as 60% across the day."
p8
aS"Cyclacel Pharmaceuticals Inc  Spikes On Tang Capital Stake Schaeffers Research  - Aug 22, 2016 After being halted earlier, Cyclacel Pharmaceuticals Inc  was last seen up 36% at $9.50. Boosting the biotech stock is a recent Securities and Exchange Commission  filing which showed Tang Capital Partners LP took a 9.6% stake in CYCC&nbsp;...Cyclacel Pharmaceuticals Inc : Don't Believe the Hype - Investorplace.comHere's Why Cyclacel Pharmaceuticals  Stock Is Surging Today - TheStreet.com"
p9
aS'Why Wall Street Is Bullish On Cyclacel Pharmaceuticals Inc.  Scibility Media - Aug 15, 2016 After Cyclacel Pharmaceuticals Inc.  released its 2Q2016 financial results and issued some operational updates, some analysts on Wall Street believe it could be a compelling stock flying under the radar.'
p10
a.